Skip to content
10-Q

Quarterly Report

QLY BIOTECH GROUP CORP.

0001477932-20-007581

← back to feed
Filed
Dec 31, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · Dec 30, 2020 3.9M sh
Capex Q1 2021 · Nov 30, 2020 $0
Capex Q1 2021 · Nov 30, 2019 $5.14K
Current Liabilities Q1 2021 · Nov 30, 2020 $7.8K
Current Liabilities Q1 2021 · Aug 31, 2020 $7.8K
Total Liabilities Q1 2021 · Nov 30, 2020 $7.8K
Total Liabilities Q1 2021 · Aug 31, 2020 $7.8K
Current Assets Q1 2021 · Nov 30, 2020 $23.52K
Current Assets Q1 2021 · Aug 31, 2020 $27.63K
Total Assets Q1 2021 · Nov 30, 2020 $26.8K
Total Assets Q1 2021 · Aug 31, 2020 $31.34K
Operating Cash Flow Q1 2021 · Nov 30, 2019 $2.48K
Cash And Equivalents Q1 2021 · Nov 30, 2019 $4.16K
Cash And Equivalents Q1 2021 · Aug 31, 2019 $5K
Stockholders Equity Q1 2021 · Nov 30, 2019 −$454
Stockholders Equity Q1 2021 · Aug 31, 2019 $2.02K
Sga Expense Q1 2021 · Nov 30, 2019 $2.48K
Net Income Q1 2021 · Nov 30, 2019 −$2.48K
Revenue Q1 2021 · Nov 30, 2019 $0